Here we focused on identifying key underlying mechanism of TGF-β regulation of metastasis in vivo by applying global proteomic analysis to metastatic lesions isolated from a preclinical mouse model of breast cancer metastasis treated with a TGF-β pathway inhibitor. The gene discussed is TGFB1; the disease is breast carcinoma.